-

Vaccine Pre-Registration Now Available for Eligible Residents via Nomi Health

OREM, Utah--(BUSINESS WIRE)--Together with the Utah Department of Health, Nomi Health, the direct healthcare company coordinating COVID-19 testing and vaccination efforts across the country, today announced that vaccine pre-registration is now available for thousands of Pfizer COVID-19 vaccine doses. Eligible residents can now pre-register to receive an appointment invitation via https://vaccines.nomihealth.com/utah.

Once registered, invitations to schedule an appointment will be sent via email to eligible residents as they become available, and in accordance with the State’s guidelines. The pre-registration process is available in both English and Spanish, and call center support is available in both languages as well.

“Our work with the State of Utah -- like elsewhere in the country -- is to harness the complexity of vaccine deployment into a seamless process that gets shots in arms as quickly as new doses become available,” said Joshua Walker, co-founder and COO, Nomi Health. “We’re proud to put our technical and operational expertise to work for Utah’s vaccine effort, and we will continue to lock arms with the State and the Department of Health to ensure as effective and efficient of an experience for all involved.”

Vaccination locations and hours of operation are:

  • Larry H. Miller Megaplex Theatres in Lehi, operating from 8 a.m. - 6 p.m.
  • Larry H. Miller Megaplex Theatres in Vineyard, operating from 8 a.m. - 6 p.m.
  • Larry H. Miller Megaplex Theatres in South Jordan, operating from 8 a.m. - 6 p.m.

Eligible groups include healthcare workers who have contact with patients, long-term care facility staff and residents, first responders, K-12 school teachers or staff, and Utahns 65 years and older. For up-to-date eligibility criteria, please visit: https://coronavirus.utah.gov/vaccine-distribution/#eligibility. For any questions, call the vaccine program helpline at (801) 704-5911.

About Nomi Health

The way we pay and deliver healthcare in America today is fundamentally broken, burdened by layers of avoidable inefficiencies that drive up costs and create unnecessary delays in care. Founded in 2019, Nomi Health is a direct healthcare company with a simple yet bold mission: rewire how we pay for and deliver healthcare to create a more cost-effective -- and simply effective -- experience for employers, patients and providers alike. Our COVID-19 public health testing and vaccine programs are a perfect example of a more direct, digital-first health care model at work. Find out more at www.nomihealth.com.

Contacts

Jenny Olson
mPR, Inc. for Nomi Health
jenny@mpublicrelations.com
310-773-2568

Nomi Health


Release Versions

Contacts

Jenny Olson
mPR, Inc. for Nomi Health
jenny@mpublicrelations.com
310-773-2568

More News From Nomi Health

CerpassRx Launches AI Engine Powered By Waltz Health to Deliver Real-Time Savings and Spend Management for Specialty Drugs

DALLAS & CHICAGO--(BUSINESS WIRE)--CerpassRx, a leader in pharmacy benefit management (PBM), today announced the launch of the Intelligent Specialty Engine, an AI-enabled platform powered by Waltz Health to manage specialty drug spend. CerpassRx’s innovative approach includes real-time analytics and specialty spend management capabilities that drive significant cost savings, improve transparency and optimize the specialty drug experience for health plan customers and their members – or self-ins...

CareSource and Nomi Health Launch Innovative Partnership to Improve Healthcare Access and Outcomes

DAYTON, Ohio--(BUSINESS WIRE)--CareSource, a non-profit health plan with over 2 million members, has selected Nomi Health to partner with it in launching a new comprehensive effort to help close gaps in healthcare access and outcomes for its Medicaid members across Ohio, Georgia, and Indiana. This collaboration aims to enhance access to essential healthcare services and improve overall health outcomes for people facing barriers to care. "This partnership with Nomi Health represents a significan...

Weight Loss Drugs Weigh Heavy on Employer Health Plans

OREM, Utah--(BUSINESS WIRE)--A meteoric rise in the popularity of glucagon-like peptide-1 (GLP-1) medications such as Ozempic, Wegovy and Mounjaro is creating financial challenges for employer-sponsored health plans. New data from Nomi Health, a company changing healthcare economics, reveals that spending on these diabetes and weight loss drugs went up 253% from 2020 to 2023, surpassing $1 billion last year and making up nearly 10% of total prescription costs for employers. Nomi Health analyzed...
Back to Newsroom